Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Allopregnanolone in PTSD
NCT07079761Phase 2Recruiting
- Sponsor
- Massachusetts General Hospital
- Start
- Aug 2025
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of brexanolone in post-traumatic stress disorder (PTSD), sponsored by Massachusetts General Hospital. Started Aug 2025; status: recruiting.
02
Drugs
brexanolone
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT07079761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07079761.